Insider · CIK 0002033818
Richard Jacroux
Files at NDRA (ENDRA Life Sciences Inc.). First filing -, latest -.
In brief
Richard Jacroux files SEC Form 4 as CFO at NDRA (ENDRA Life Sciences Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Richard Jacroux has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | NDRA ENDRA Life Sciences Inc. | AGrant or award Common Stock | +13,461 | $0.00 | $0 | 33,461 | Mar 4, 2026 |
| Jan 21, 2026 | NDRA ENDRA Life Sciences Inc. | AGrant or award Common Stock | +20,000 | $0.00 | $0 | 20,000 | Jan 23, 2026 |
Questions about Richard Jacroux
Answered from the filings on this page, as of the latest one.
Is Richard Jacroux buying or selling?
Richard Jacroux has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Richard Jacroux's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard Jacroux has 0.
Where does Richard Jacroux file Form 4?
Richard Jacroux has filed Form 4 at NDRA (ENDRA Life Sciences Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.